Lovenox Generics Might Be Slowed In U.S. Because Of EU Guidance, Sanofi Hopes

Sanofi-Aventis says an emerging European guideline prescribing clinical trials for low molecular weight heparin generics could sway FDA as it considers copies of its clot-busting blockbuster Lovenox